These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1117 related articles for article (PubMed ID: 123336)

  • 41. Test for malignant transformation of rat liver cells in culture: cytology, growth in soft agar, and production of plasminogen activator.
    Montesano R; Drevon C; Kuroki T; Saint Vincent L; Handleman S; Sanford KK; DeFeo D; Weinstein IB
    J Natl Cancer Inst; 1977 Dec; 59(6):1651-8. PubMed ID: 562943
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Plasminogen activator and plasmin-like activities in experimental rat tumours.
    Tözsér J; Hamvas A; Rády P; Kertai P; Elödi P
    Acta Biochim Biophys Hung; 1989; 24(1-2):119-28. PubMed ID: 2558473
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Suppression of type I collagenase expression by antisense RNA in melanoma cells results in reduced synthesis of the urokinase-type plasminogen activator receptor.
    Durko M; Brodt P
    Biochem Biophys Res Commun; 1998 Jun; 247(2):342-8. PubMed ID: 9642128
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reexamination of the role of plasminogen activator production for growth in semisolid agar of neoplastic hamster cells.
    Barrett JC; Sheela S; Ohki K; Kakunaga Takeo
    Cancer Res; 1980 May; 40(5):1438-42. PubMed ID: 7189446
    [No Abstract]   [Full Text] [Related]  

  • 45. [Effect of bioresolving microspheric preparations of immobilized fibrinolysin on the fibrinolysis system].
    Bessolitsyna LA; Mazaev AB; Markosian RA; Suvorov AV; Torchilin VP
    Biull Eksp Biol Med; 1980; 89(1):16-8. PubMed ID: 6445763
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro differentiation of teratomas and the distribution of creatine phosphokinase and plasminogen activator in teratocarcinoma-derived cells.
    Topp W; Hall JD; Marsden M; Teresky AK; Rifkin D; Levine AJ; Pollack R
    Cancer Res; 1976 Nov; 36(11 Pt. 2):4217-23. PubMed ID: 184930
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Binding and activation of plasminogen on the surface of osteosarcoma cells.
    Campbell PG; Wines K; Yanosick TB; Novak JF
    J Cell Physiol; 1994 Apr; 159(1):1-10. PubMed ID: 7511144
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Effects of heparin on plasmin and plasminogen activation].
    Manmi S
    Nihon Ketsueki Gakkai Zasshi; 1971 Oct; 34(5):591-4. PubMed ID: 4261759
    [No Abstract]   [Full Text] [Related]  

  • 49. Coordinated expression of the vitronectin receptor and the urokinase-type plasminogen activator receptor in metastatic melanoma cells.
    Nip J; Rabbani SA; Shibata HR; Brodt P
    J Clin Invest; 1995 May; 95(5):2096-103. PubMed ID: 7537755
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Active transforming growth factor-beta in human melanoma cell lines: no evidence for plasmin-related activation of latent TGF-beta.
    Bizik J; Felnerova D; Grofova M; Vaheri A
    J Cell Biochem; 1996 Jul; 62(1):113-22. PubMed ID: 8836880
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
    Matsuo O; Rijken DC; Collen D
    Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Studies on fibrinolysis and ascites accumulation associated with peritonitis carcinomatosa--inducer of plasminogen activator (IPA) in malignant ascites tumor].
    Shibata J
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 May; 38(5):735-40. PubMed ID: 2941504
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro correlates of transformation in C3H/10T1/2 clone 8 mouse cells.
    Jones PA; Laug WE; Gardner A; Nye CA; Fink LM; Benedict WF
    Cancer Res; 1976 Aug; 36(8):2863-7. PubMed ID: 1277196
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differentiation of neuroblastoma cells induced in culture by 6-thioguanine.
    Prasad KN
    Int J Cancer; 1973 Nov; 12(3):631-6. PubMed ID: 4151604
    [No Abstract]   [Full Text] [Related]  

  • 55. Production of plasminogen activator and inhibition of embryonic cell aggregation by cultured human normal and neoplastic cells.
    Phan Thu A; Popovic M
    Neoplasma; 1979; 26(6):663-75. PubMed ID: 575560
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Blood coagulation mechanism from the viewpoint of molecular biochemistry: Mechanism of fibrinolysis].
    Matsuda T
    Rinsho Byori; 1985 Sep; 33(9):982-8. PubMed ID: 2416968
    [No Abstract]   [Full Text] [Related]  

  • 57. [Animal experimental studies on fibrinolysis with streptokinase].
    Hauptmann J; Klöcking HP
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(5-6):915-22. PubMed ID: 94886
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A polypeptide secreted by transformed cells that modulates human plasminogen activator production.
    Davies RL; Rifkin DB; Tepper R; Miller A; Kucherlapati R
    Science; 1983 Jul; 221(4606):171-3. PubMed ID: 6682999
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Suppression of fibrinolysin T activity fails to restore density-dependent growth inhibition to SV3T3 cells.
    Chou IN; Black PH; Roblin RO
    Nature; 1974 Aug; 250(5469):739-41. PubMed ID: 4370416
    [No Abstract]   [Full Text] [Related]  

  • 60. Effect of 5-bromodeoxyuridine on mouse myeloma cells.
    Pettengill OS; Sorenson GD
    In Vitro; 1974; 10(5-6):274-80. PubMed ID: 4452560
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 56.